Methodology Working Party

The Methodology Working Party (MWP) was established by the Committee for Medicinal Products for Human Use (CHMP) in order to pool and use expertise in key areas such as biostatistics, modelling and simulation, pharmacokinetics, pharmacogenomics, and real-world evidence.

The MWP's tasks include:

• providing product-related support when requested by EMA Committees and the Scientific Advice Working Party; 
• engaging with stakeholders including international regulators, associations of pharmaceutical companies, and patient and healthcare professional organisations;
• preparing, reviewing and updating guidelines and concept papers;
• providing training and workshops to assessors.

Mandate, rules of procedure and work programme

EMA will provide information on the mandate, responsibilities and procedures of this working party as soon as available.

The current three-year work plan is available below:

Consolidated 3-year rolling work plan for the Methodology Working Party 2025-2027

AdoptedReference Number: EMA/324489/2024

Composition

The MWP is composed of European experts nominated by CHMP members taking into consideration the best available expertise needed to deliver its commitments.

The current members are listed below, in alphabetical order of surname.

Their declarations of interests are available in the European expert list:

• European experts